FDA approves first generic of Novo Nordisk’s Victoza Posted on December 23, 2024 by wpadmin Hailshadow/iStock via Getty Images The U.S. FDA has approved the first generic version of Novo Nordisk’s (NVO) GLP-1 for type 2 diabetes, Victoza (liraglutide). The approval was granted to Hikma Pharmaceuticals USA. The agency noted that brand-named Victoza is currently in shortage. An authorized
